Barrett Esophagus Clinical Trial
Official title:
Does Laparoscopic Sleeve Gastrectomy Lead to Barrett's Esophagus, 5-year Esophagogastroduodenoscopy Findings: A Retrospective Cohort Study
Verified date | October 2020 |
Source | Jaber Al Ahmad Al Sabah Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Introduction Laparoscopic Sleeve Gastrectomy (LSG) is one of the most prevalent approaches to
tackle obesity and its co-morbidities. The main complication following the LSG is
Gastro-esophageal reflux disease (GERD), with most patients developing worsening symptoms of
GERD, and a small number progressing to Barrett's esophagus. This retrospective analysis aims
to assess the rate of GERD pre- and post- LSG as well as the rate of progression to
Barrett's.
Methods Data was collected from 1639 patients. 92 patients fit our inclusion criteria. Data
was then analyzed and summarized against similar literature
Status | Completed |
Enrollment | 92 |
Est. completion date | September 20, 2020 |
Est. primary completion date | October 1, 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 24 Years to 36 Years |
Eligibility |
Inclusion Criteria: - patients eligible to sleeve gastrectomy that had an EGD pre and 5 years post-op Exclusion Criteria: - missing or implausible data, had multiple surgeries, and suffered from the common post-sleeve complications, such as leaks, strictures and hiatal hernias |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Eliana Al Haddad |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | endoscopy performed on patients | endoscopy will be performed on patients 5 years after undergoing sleeve gastrectomy due to the fact that sleeve tends to lead to reflux which causes dysplasia of esophageal cells, which eventually can lead to barrett's esophagus and cancer. | 5 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03554356 -
Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)
|
N/A | |
Completed |
NCT03015389 -
Wide Area Transepithelial Sample Esophageal Biopsy Combined With Computer Assisted 3-Dimensional Tissue Analysis (WATS3D) For the Detection of High Grade Esophageal Dysplasia and Adenocarcinoma
|
||
Completed |
NCT03434834 -
OCT Pilot in Esophagus
|
N/A | |
Terminated |
NCT04642690 -
Nitrates and IL-8 in Barrett's Esophagus
|
||
Completed |
NCT03468634 -
Raman Probe for In-vivo Diagnostics (During Oesophageal) Endoscopy
|
N/A | |
Recruiting |
NCT02310230 -
An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy
|
N/A | |
Completed |
NCT00217087 -
Endoscopic Therapy of Early Cancer in Barretts Esophagus
|
Phase 2 | |
Completed |
NCT02284802 -
Early Detection of Tumors of the Digestive Tract by Confocal Endomicroscopy
|
N/A | |
Recruiting |
NCT05530343 -
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
|
N/A | |
Active, not recruiting |
NCT04151524 -
Classification of Adenocarcinoma of the Esophagogastric Junction
|
||
Completed |
NCT00955019 -
Novel Method of Surveillance in Barrett's Esophagus
|
Phase 2 | |
Terminated |
NCT00386594 -
Pilot Study of Oral 852A for Elimination of High-Grade Dysplasia in Barrett's Esophagus
|
N/A | |
Completed |
NCT00576498 -
Novel Imaging Techniques in Barrett's Esophagus
|
N/A | |
Completed |
NCT02688114 -
Healing of the Esophageal Mucosa After RFA of Barrett's Esophagus
|
N/A | |
Recruiting |
NCT06071845 -
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
|
N/A | |
Completed |
NCT02560623 -
A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus
|
N/A | |
Recruiting |
NCT05056051 -
Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's Esophagus
|
N/A | |
Recruiting |
NCT04001478 -
Non-invasive Testing for Early oEesophageal Cancer and Dysplasia
|
||
Completed |
NCT03859557 -
The Evaluation of Patients With Esophageal and Foregut Disorders With WATS (Wide Area Transepithelial Sample With 3-Dimensional Computer-Assisted Analysis) vs. 4-Quadrant Forceps Biopsy
|
||
Recruiting |
NCT05107219 -
GCC Agonist Signal in the Small Intestine
|
Phase 1 |